@ Newsroom | SEBIO

Celebration of Biotechnology Showcases Alachua Companies

Posted by on May 25, 2016 in Newsroom | 0 comments

ALACHUA, FL. – The city of Alachua continued to demonstrate its status as an emerging leader in biotechnology last Thursday, when RTI Surgical hosted the 13th Annual BioFlorida Celebration of Biotechnology in Progress Park. From 9:30 a.m. to 1 p.m., the showcase brought more than 80 exhibitors and 500 professionals from the state and country to network as well as present their new products. Some of the key spokespeople included Nancy Bryan, the president and CEO of BioFlorida, David Day, the assistant vice principal and director of UF’s Office of Licensing Technology and Mark Long,...

Read More

Arbor Pharmaceuticals to Acquire XenoPort

Posted by on May 24, 2016 in Newsroom | 0 comments

ATLANTA, GA. & SANTA CLARA, CA. – Arbor Pharmaceuticals, LLC (Arbor) and XenoPort, Inc. (XenoPort) (NASDAQ:XNPT) announced today that they have signed a definitive agreement under which Arbor will acquire XenoPort for $7.03 per share in cash, or a total equity value of approximately $467 million. The purchase price per share represents a 60 percent premium to the closing price of XenoPort shares on May 20, 2016. “We are pleased to be adding HORIZANT and the XenoPort pipeline to the growing portfolio of Arbor products,” said Ed Schutter, President and Chief Executive Officer of...

Read More

Georgia BioEd Institute Hires Executive Director

Posted by on May 24, 2016 in Newsroom | 0 comments

ATLANTA, GA. – Georgia Bio, a private, non-profit association that promotes the life sciences industry in Georgia, is thrilled to announce Jordan Rose as the new Executive Director of the Georgia BioEd Institute. Rose will be responsible for strategic and operational direction to fulfill the organization’s mission to grow Georgia’s leadership in life science innovation. As the Executive Director, Rose will drive and enhance program development strategies, strengthen fiscal and operational effectiveness, and improve the organization’s standing in Georgia. Leveraging the Georgia...

Read More

Wilmington’s impressive biotech, life science entrepreneurial potential

Posted by on May 24, 2016 in Newsroom | 0 comments

WILMINGTON, N.C. – I had an exciting adult field trip in my own town, within my own university, as I explored the world of biotechnology and life science business opportunities in Wilmington. To start the journey [on May 19], I joined Pharmacologist and Forbes writer, Dr. David J. Kroll for lunch at the invitation of fellow University of Florida graduate and Network for Entrepreneurs in Wilmington (NEW) founder, Jim Roberts. After a great lunch at a highly rated foodie local deli, Dr. Daniel Baden, Director of Biotechnology at UNCW’s CREST Research Park gave me and David a tour of...

Read More

Axion BioSystems completes successful equity financing

Posted by on May 17, 2016 in Newsroom | 0 comments

ATLANTA, GA. – Axion BioSystems, a manufacturer of the Maestro multiwell microelectrode array (MEA) platform, is pleased to announce that the Company successfully closed a $6 million equity financing. The additional capital will accelerate the growth of Axion’s core life science instrumentation product line. “Axion’s products are being adopted around the world at an ever-increasing rate,” said CEO Tom O’Brien. “To maintain our rapid growth, we need to further invest in our global sales channel and in the support system for our expanding list of...

Read More

Asana Medical, Inc. Announces Closing of $1.2 Million Convertible Promissory Note Offering

Posted by on May 12, 2016 in Newsroom | 0 comments

MIAMI LAKES, FL. – Asana Medical, Inc. (“Asana,” the “Company”) is pleased to announce that it has closed a $1.2 million offering of convertible promissory notes. Asana, an emerging life sciences company, is focused on the development and commercialization of an innovative therapy to non-surgically treat Inflammatory Bowel Diseases (“IBD”), including Ulcerative Colitis (“UC”), Crohn’s Disease and Rectal Mucositis. Asana’s lead product, ExtraCellular Matrix Hydrogel (“ECMH”), is a hydrogel composed of extracellular...

Read More